Institut Mérieux is contributing its experience in biology to improve medicine and public health across the globe.
To fight against infectious diseases and cancer, the Institute imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition.
Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working closely with its entities devoted to innovation (such as ABL Inc. and Mérieux Développement), have contributed to major advances in medicine and public health.
Institut Mérieux employs more than 17,000 people around the world and is present in over 40 countries, with more than 2.6 billion euros in sales.
family-owned holding company
companies working on public health all over the world
Areas of activity
in vitro diagnostics, immunotherapy, food safety, nutrition
Established in more than
Sales in 2016
> €2,600 M